| CAS ID: | P01308 |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Protein based biotech |
| Natural Product: | No |
| Other Names: | |
| Analysis: | N/A |
Reference Record 1
| PubMed ID | 26812497 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,rat | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSCs activation | ||
| Process III | |||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT00231192 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Withdrawn |
| First Received | October 4, 2005 | Last Verified | March 12, 2015 |
| Sponsor | Children's Hospital of Philadelphia | ||
Trial Record 2
| ClinicalTrial ID | NCT02653300 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Recruiting |
| First Received | January 12, 2016 | Last Verified | December 10, 2018 |
| Sponsor | Oramed, Ltd. | ||
Trial Record 3
| ClinicalTrial ID | NCT02234440 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | September 9, 2014 | Last Verified | February 8, 2018 |
| Sponsor | Institute of Liver and Biliary Sciences, India | ||
Trial Record 4
| ClinicalTrial ID | NCT02396888 | Disease | Fibrosis |
| Phase | Phase 3 | Status | Unknown |
| First Received | March 24, 2015 | Last Verified | March 24, 2015 |
| Sponsor | Hospital Central "Dr. Ignacio Morones Prieto" | ||